These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9664139)

  • 1. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.
    Gazitt Y; Fey V; Thomas C; Alvarez R
    Int J Oncol; 1998 Aug; 13(2):397-405. PubMed ID: 9664139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 overexpression is associated with resistance to paclitaxel, but not gemcitabine, in multiple myeloma cells.
    Gazitt Y; Rothenberg ML; Hilsenbeck SG; Fey V; Thomas C; Montegomrey W
    Int J Oncol; 1998 Oct; 13(4):839-48. PubMed ID: 9735415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
    Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
    J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan.
    Trudel S; Stewart AK; Li Z; Shu Y; Liang SB; Trieu Y; Reece D; Paterson J; Wang D; Wen XY
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):621-9. PubMed ID: 17255285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan.
    Rowley M; Liu P; Van Ness B
    Blood; 2000 Nov; 96(9):3175-80. PubMed ID: 11050000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2.
    Feinman R; Koury J; Thames M; Barlogie B; Epstein J; Siegel DS
    Blood; 1999 May; 93(9):3044-52. PubMed ID: 10216101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of p53, bcl-2 and bax network in dexamethasone induced apoptosis in multiple myeloma cell lines.
    Tian E; Gazitt Y
    Int J Oncol; 1996 Apr; 8(4):719-26. PubMed ID: 21544419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells.
    Chauhan D; Ray A; Viktorsson K; Spira J; Paba-Prada C; Munshi N; Richardson P; Lewensohn R; Anderson KC
    Clin Cancer Res; 2013 Jun; 19(11):3019-31. PubMed ID: 23584492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of dexamethasone-, paclitaxel-, and Ad-p53-induced apoptosis by Bcl-2 antisense oligodeoxynucleotides in drug-resistant multiple myeloma cells.
    Liu Q; Gazitt Y
    Blood; 2003 May; 101(10):4105-14. PubMed ID: 12521996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myeloma.
    Iyer R; Ding L; Batchu RB; Naugler S; Shammas MA; Munshi NC
    Leuk Res; 2003 Jan; 27(1):73-8. PubMed ID: 12479855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas (APO-1/CD95)-mediated apoptosis is independent of bcl-2: a study with cell lines overexpressing bcl-2 and with bcl-2 transfected cell lines.
    Gazitt Y; Hu WX
    Int J Oncol; 1998 Jan; 12(1):211-20. PubMed ID: 9454907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
    Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
    Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by dexamethasone of transforming growth factor beta1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction.
    Yamamoto M; Fukuda K; Miura N; Suzuki R; Kido T; Komatsu Y
    Hepatology; 1998 Apr; 27(4):959-66. PubMed ID: 9537434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.
    Maiso P; Carvajal-Vergara X; Ocio EM; López-Pérez R; Mateo G; Gutiérrez N; Atadja P; Pandiella A; San Miguel JF
    Cancer Res; 2006 Jun; 66(11):5781-9. PubMed ID: 16740717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.
    Wu Y; Wang H
    J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29205703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA.
    Park GB; Kim YS; Kim D; Kim S; Lee HK; Cho DH; Lee WJ; Hur DY
    J Immunol; 2013 Dec; 191(12):6281-91. PubMed ID: 24249729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
    Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
    Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?
    Weller M; Schmidt C; Roth W; Dichgans J
    Neurology; 1997 Jun; 48(6):1704-9. PubMed ID: 9191791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenously generated hydrogen peroxide is required for execution of melphalan-induced apoptosis as well as oxidation and externalization of phosphatidylserine.
    Matsura T; Kai M; Jiang J; Babu H; Kini V; Kusumoto C; Yamada K; Kagan VE
    Chem Res Toxicol; 2004 May; 17(5):685-96. PubMed ID: 15144226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.